Dianthus Therapeutics
Dianthus Therapeutics is seeking a Senior Medical Science Liaison to support the advancement of its neuromuscular disease portfolio, including myasthenia gravis, CIDP, and MMN. This field-based role involves building strategic relationships with key opinion leaders and healthcare professionals while serving as a scientific expert and trusted partner. The position requires generating actionable insights, supporting clinical development, and contributing to future launch readiness efforts.
Dianthus Therapeutics is a biotechnology company focused on developing next‑generation antibody therapeutics that target the complement system to address diseases with high unmet medical need. The company engineers selective, potent complement‑modulating antibodies with the goal of improving safety and efficacy over existing therapies. Dianthus advances novel antibody candidates toward clinical development and is committed to translating complement biology into meaningful treatments for patients.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Dianthus Therapeutics.
Dianthus Therapeutics didn’t post a salary, so this is our estimate from similar listings.
22% below the average for this role
Truist Financial Forecasts Strong Price Appreciation for Dianthus Therapeutics (NASDAQ:DNTH) Stock
2 hours ago